- PPAR MODULATORS
-
The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
- -
-
Page/Page column 127
(2010/02/11)
-
- HALOGEN SUBSTITUTED 3,3-DIPHENYLPROPYLAMINES (TOLTERODINE) HAVING ANTIMUSCARINIC ACTIVITY
-
Novel 3,3-diphenylpropylamines of the formula OR, and any stereoisomers thereof; wherein R1 represents -H or -CH3; R2 represents -CX3r -CR2_1X2r-CR2_1R2_2X, or -CR2_1R2_2H, wherein X represents halogen, and R2_1 and R
- -
-
Page 11; 14-16
(2010/02/09)
-